Dr. Mary Beth Seegars, MD
- Medicare services, 2024
- 289
- Medicare patients, 2024
- 129
- Part D claims, 2024
- 284
- Publications
- 9
- Clinical trials
- 4
- Practice address
- 329 Nc Highway 801 N, Bermuda Run, NC 27006
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Davie Surgery - Ophthalmology - HOPD
Acute Care Hospital outpatient department · Bermuda Run, North Carolina
Find Dr. Seegars' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mary Beth Seegars is a hematologist and oncologist in Advance, North Carolina
Dr. Seegars practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.
Dr. Seegars' NPI, 1184064073, was assigned on June 25, 2013. Dr. Seegars graduated from University of South Carolina School of Medicine in 2013. Dr. Seegars holds North Carolina license 2019-01445.
- NPI
- 1184064073NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5597051219
- NPI enumeration date
- June 25, 2013
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 39
- Medical school graduation
- 2013
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mary Beth Seegars practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina
Dr. Seegars' primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.
- Davie Surgery - Ophthalmology - HOPD329 Nc Highway 801 N, Bermuda Run, NC 27006
Source: Dmand AI Affiliation Data
Dr. Mary Beth Seegars is affiliated with 3 sites of care and 1 medical group
Dr. Seegars' primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Seegars is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Seegars to 1 more hospital, named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Mary Beth Seegars' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seegars practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Davie Surgery - Ophthalmology - HOPD | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mary Beth Seegars is one of 420 hematologists and oncologists in North Carolina
Hematology and oncology is Dr. Seegars' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Seegars' licenses on file in 2 states: North Carolina and South Carolina.
Specialties and state licenses
- Hematology and oncology, North CarolinaPrimary
- Internal medicine, South Carolina
Hematologists and oncologists near Dr. Seegars
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mary Beth Seegars billed Medicare for 289 services in 2024
CMS data shows 289 Medicare services from Dr. Seegars across 3 procedure codes in 2024, for 129 Medicare patients. Medicare paid $21,009 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Seegars' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4402024: 28934%
Dr. Seegars compared with the North Carolina median for hematologists and oncologists, 2024
- Dr. Seegars
- North Carolina median
- Medicare services
- 289vs 45036% below
- Medicare patients
- 129vs 18028% below
- Part D claims
- 109vs 32466% below
Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Seegars' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Seegars?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Seegars and other hematologists and oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mary Beth Seegars treated 129 Medicare patients in 2024, average age 71
CMS counts 129 Medicare patients who saw Dr. Seegars in 2024. The largest group is 65 to 74, with 59 patients. 71% of them have high blood pressure, and 69% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Seegars' median patient age at 72, with 49% women.
Dr. Seegars' Medicare patients by age, 2024
Dr. Seegars' Medicare patients by sex, 2024
- Women6047%
- Men6953%
Chronic conditions among Dr. Seegars' Medicare patients, 2024
- High blood pressure71%
- High cholesterol69%
- Arthritis38%
- Mood disorders35%
- Depression33%
- Anxiety29%
- Chronic kidney disease29%
- Diabetes26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Seegars' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women49%
- Men51%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mary Beth Seegars wrote 284 Medicare Part D claims in 2024
In 2024, Dr. Seegars wrote 284 Medicare Part D claims for 54 patients. 71% of them were for generic drugs. CMS names the drug for 109 of them, across 7 drugs with 11 or more claims each, at $303,305 in total drug cost. In 2023, CMS named 138 claims across 9 drugs.
Dr. Seegars' Part D claims by kind of drug, 2024
- Generic203 claims71%
- Brand-name and other81 claims29%
Dr. Seegars' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Seegars' Part D claims, 2024
- Antibiotics11%31 of 284 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1382024: 10921%
Drugs named by CMS: 7 in 2024, 9 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Mary Beth Seegars takes part in Medicare
Dr. Seegars accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mary Beth Seegars has 9 publications on record
Dmand AI links 9 papers to Dr. Seegars, published from 2015 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Splenic Infarction. Dr. Seegars' most frequent co-authors are Allan S. Brett, MD, Tamjeed Ahmed, MD and Christine Ahn, MD.
Dr. Seegars' papers by year, 2015 to 2025
Topics Dr. Seegars writes about most
- Splenic Infarction
Dr. Seegars' most frequent co-authors
Recent publications by Dr. Seegars
See who Dr. Seegars researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Seegars works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mary Beth Seegars has worked on 4 clinical trials
Dmand AI links Dr. Seegars to 4 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Hodgkin Disease, Lymphoma and Lymphoma, B-Cell. National Cancer Institute (NCI) sponsors the most, 2.
Clinical trials with Dr. Seegars by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Seegars' trials
- Hodgkin Disease
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
Investigators on the most trials with Dr. Seegars
- Dahlia Sano, MD3 shared trials
- Charles M. Farber, MD, PhD2 shared trials
- Mitul D. Gandhi, MD2 shared trials
Recent clinical trials with Dr. Seegars
Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects (opens in a new tab)
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) (opens in a new tab)
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mary Beth Seegars received $1,417 in industry payments from 2016 to 2025
CMS Open Payments shows 16 general payments to Dr. Seegars from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Genentech, Inc. paid the most, $393.
General payments to Dr. Seegars by program year, 2016 to 2025
General payments to Dr. Seegars by kind, 2016 to 2025
- Food and beverage$1,13380%
- Education$28420%
Companies that paid Dr. Seegars the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mary Beth Seegars graduated from University of South Carolina School of Medicine
Dr. Seegars graduated from University of South Carolina School of Medicine in 2013.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Mary Beth Seegars's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mary Beth Seegars
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mary Beth Seegars' NPI number?
Dr. Mary Beth Seegars' NPI number is 1184064073. It was assigned on June 25, 2013, and it is active in the NPI Registry.
What kind of doctor is Dr. Mary Beth Seegars?
Dr. Mary Beth Seegars is a hematologist and oncologist in Advance, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Mary Beth Seegars practice?
Dr. Seegars practices at 329 Nc Highway 801 N, Bermuda Run, NC 27006. Dr. Seegars' primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dmand AI also links Dr. Seegars to 1 hospital.
What is Dr. Mary Beth Seegars' medical license number?
Dr. Seegars holds North Carolina license 2019-01445, one of the licenses on file in 2 states.
Which states has Dr. Mary Beth Seegars been licensed in?
Dmand AI has state licenses on file for Dr. Seegars in North Carolina and South Carolina.
Which hospitals is Dr. Mary Beth Seegars affiliated with?
Dr. Seegars is affiliated with Atrium Health Wake Forest Baptist Medical Center. Dmand AI links Dr. Seegars to 1 more hospital.
What medical group is Dr. Mary Beth Seegars part of?
Dr. Seegars is linked to Atrium Health Wake Forest Baptist.
Does Dr. Mary Beth Seegars accept Medicare?
Yes. CMS data shows Dr. Seegars billed Medicare for 289 services in 2024, and Dr. Seegars accepts Medicare assignment.
How many Medicare patients does Dr. Mary Beth Seegars see?
CMS counts 129 Medicare patients who saw Dr. Seegars in 2024, with an average age of 71.
What services does Dr. Mary Beth Seegars bill to Medicare?
In 2024, Dr. Seegars' most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99233) and office visit, established patient (99215).
Show 6 more questionsShow fewer questions
Where did Dr. Mary Beth Seegars go to medical school?
Dr. Seegars graduated from University of South Carolina School of Medicine in 2013.
What drugs does Dr. Mary Beth Seegars prescribe most?
In 2024 Medicare Part D data, Dr. Seegars' most prescribed drugs by claims were Dexamethasone, Acyclovir and Ondansetron HCl.
Has Dr. Mary Beth Seegars received payments from drug or device companies?
CMS Open Payments shows $1,417 in general payments to Dr. Seegars from 10 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Mary Beth Seegars been practicing?
Dr. Seegars graduated from medical school in 2013, 13 years ago.
Does Dr. Mary Beth Seegars do research?
Dmand AI links 9 publications to Dr. Seegars, published from 2015 to 2025. Dr. Seegars has worked on 4 clinical trials.
Who does Dr. Mary Beth Seegars publish with?
Dr. Seegars' most frequent co-authors are Allan S. Brett, MD (2 shared papers), Tamjeed Ahmed, MD (1 shared paper) and Christine Ahn, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card